News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioSolveIT And Cambridge Crystallographic Data Centre Release World Class Fragments for Top Quality Drug design


3/24/2010 11:18:30 AM

ST. AUGUSTIN, Germany & CAMBRIDGE, England--(BUSINESS WIRE)--BioSolveIT GmbH in conjunction with The Cambridge Crystallographic Data Centre (CCDC) today announced the release of an exclusive set of fragments for 3D-based computational drug design. The Cambridge Structural Database (CSD) is a key global source for crystal structures and a major resource for the chemical and pharmaceutical industries. It provides the basis for the highest quality input fragment data for successful fragment-based lead discovery (FBLD) with LeadIT. Dr. Colin Groom, Executive Director of the CCDC said that “Precise crystal structure data is crucial for underpinning knowledge-based applications software. The CCDC is committed to combining the strengths of the CSD with third-party applications, and we are very pleased to be working with BioSolveIT in this capacity.”

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES